Skip to content
Screener

Penumbra PEN Q2 2025 earnings

Reported July 29, 2025 · After market close

Revenue$339.5MMiss by $1.9M
EPS$0.86Beat by $0.05
Revenue estimate$341.3M
EPS estimate$0.81

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$401.4M
EPS estimate$1.20

Financials

Q2 2025

Income statement

See full
Revenue$339.5M+13.4%
Gross profit$224.0M+37.6%
Operating income$40.8M+150%
Net income$45.3M+175%
EPS (diluted)$1.15+174%

Balance sheet

See full
Cash & equivalents$421.8M+46.3%
Total debt$220.5M-3.6%
Total equity$1.3B+11.4%
Total assets$1.7B+9.1%

Cash flow

See full
Operating cash flow$44.9M+98.8%
CapEx$15.6M+243%
Free cash flow$29.4M+62.5%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$9.9B+42.1%
Enterprise value$9.7B+40.4%
P/E67×-422×
P/S7.7×+1.6×

Profitability

See full
Gross margin66.5%+4.0pp
Operating margin12.4%+11.0pp
Net margin11.5%+10.3pp
FCF margin12.6%+2.9pp

Returns & leverage

See full
Return on equity12%+10.8pp
Debt / equity0.2×0.0×
Current ratio6.8×+0.5×

Segments

By product

See full
Thrombectomy$230.3M+13.1%
Embolization and Access$109.2M+13.9%

FAQ

When did Penumbra report Q2 2025 earnings?
Penumbra (PEN) reported Q2 2025 earnings on July 29, 2025 after market close.
What were Penumbra's Q2 2025 revenue and EPS?
Penumbra reported revenue of $339.5M and eps of $0.86 for Q2 2025.
Did Penumbra beat estimates in Q2 2025?
Revenue missed the consensus estimate of $341.3M by $1.9M. EPS beat the consensus estimate of $0.81 by $0.05.
How did Penumbra's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 13.4% from $299.4M a year earlier and eps grew 34.4% from $0.64.
Where can I find Penumbra's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001321732-25-000097) and the 10-Q periodic report (0001321732-25-000098) directly on SEC EDGAR. The filing index links above go to sec.gov.